CD152/Fc Chimera, Non-cytolytic from mouse, >=99% (SDS-PAGE), recombinant, expressed in NS.1 cells, buffered aqueous solution

Code: c4358-1mg D2-231

Biochem/physiol Actions

CD152 (CTLA4), a cell surface glycoprotein expressed at low levels on activated T cells, is a high affinity receptor for the costimulatory molecules C...


read more

Your Price
£528.00 1MG
£633.60 inc. VAT

Biochem/physiol Actions

CD152 (CTLA4), a cell surface glycoprotein expressed at low levels on activated T cells, is a high affinity receptor for the costimulatory molecules CD80 (B7-1) and CD86 (B7-2). A related cell surface glycoprotein, CD28, binds to CD80 and CD86 with lower affinity. The soluble CD152/Fc chimeric fusion protein blocks the B7/CD28 signaling pathway by binding to CD80 and CD86.

General description

The extracellular domain (160 amino acids) of mouse CD152 is fused to mouse IgG2a Fc domain in which mutations to the complement (C1q) and FcγR I binding sites of the Fcγ2a fragment render the Fc fusion protein incapable of direct antibody directed cytotoxicity (ADCC) and complement directed cytotoxicity (CDC).

Physical form

Lyophilized from solution of 0.2 µm filtered, in phosphate buffered saline, pH 7.4, with no preservative added.

Preparation Note

Purified from serum-free tissue culture supernatant

assay≥98% (SDS-PAGE)
formlyophilized
Gene Informationmouse ... Ctla4(12477)
mol wt97 kDa
Quality Level200
recombinantexpressed in NS.1 cells
shipped inwet ice
storage temp.−20°C
UniProt accession no.P09793
This product has met the following criteria: